LDHC mRNA has been detected in serum and serum-derived exosomes of patients with BC (36), HCC (37), and LUAD (63), and the source may be related to vesicle encapsulation of tumor cells and release of necrotic tumor cells into the peripheral blood. Here, LDHC is linked to breast cancer.